CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $28,799,000 | +12207.3% | 852,040 | +8420.4% | 0.02% | – |
| Q1 2021 | $234,000 | -97.5% | 10,000 | -96.9% | 0.00% | -100.0% |
| Q4 2020 | $9,293,000 | -0.1% | 322,684 | -29.7% | 0.01% | -36.4% |
| Q3 2020 | $9,305,000 | +38.8% | 459,286 | +105.9% | 0.01% | +22.2% |
| Q2 2020 | $6,704,000 | -53.4% | 223,101 | -51.2% | 0.01% | -71.9% |
| Q1 2020 | $14,381,000 | -47.3% | 457,568 | -20.9% | 0.03% | -8.6% |
| Q4 2019 | $27,267,000 | +16941.9% | 578,799 | +2332.2% | 0.04% | – |
| Q3 2018 | $160,000 | – | 23,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |